Scarica l'app Stockscreener
77.90
1.86%
-1.2211
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Merck Co Inc Borsa (MRK) Ultime notizie
Merck launches $895M Kansas factory expansion amid push to increase domestic production - Crain's New York Business
Merck Animal Health will spend $895M on 200-job expansion in De Soto - The Business Journals
Merck boosts U.S. investments with $895M expansion in Kansas site - MSN
Merck (MRK) to Invest $895M in Kansas Facility Expansion - GuruFocus
Merck announces $895M expansion in Kansas site (MRK:NYSE) - Seeking Alpha
2 Beaten-Down Stocks That Are Great Buys on the Dip - The Motley Fool
Merck Animal Health announces $895M expansion, new jobs in De Soto - FOX4KC.com
Merck (MRK) Plans Major Expansion of Animal Health Facility in Kansas | MRK Stock News - GuruFocus
Merck Animal Health announces $895 million investment in Kansas - Reuters
Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto - Stock Titan
Is Merck & Co., Inc. (MRK) the Best Dow Stock? - MSN
Merck (NYSE:MRK) Launches Next-Gen Digital Ecosystem for Growth Disorders with Dawn Health - Yahoo Finance
Merck’s New Keytruda Shot Is a Rare Real-Time ‘Product Hop’ (1) - Bloomberg Law News
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential - Insider Monkey
Merck to Participate in the Bank of America 2025 Global Healthcare Conference - Business Wire
Multiple System Atrophy (MSA) Market Research 2025-2035 - GlobeNewswire Inc.
Dawn Health and Merck Launch Next-Generation Digital Ecosystem for Growth Disorders - marketscreener.com
FDA Plans to Increase Surprise Inspections at Overseas Manufacturing Sites - marketscreener.com
Are Wall Street Analysts Bullish on Merck Stock? - Nasdaq
Long-Term Investors in shares of Merck & Co., Inc. (NYSE: MRK) - openPR.com
Merck & Co Unusual Options Activity - Nasdaq
Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now? - Yahoo Finance
Are Wall Street Analysts Bullish On Merck Stock? - Barchart.com
FDA Action Alert: GSK, Sanofi, Merck and More - BioSpace
Merck invests $1B in Wilmington facility to boost U.S. drug production amid tariff concerns - Audacy
Merck Expands Biomanufacturing with Staggering Investment in Wilmington - VISTA.Today
Merck & Co., Inc. SEC 10-Q Report - TradingView
Merck Stock Price | MRK Stock Quote, News, and History - markets.businessinsider.com
Merck & Co. CMO Barr On Breaking Into Immunology And Ophthalmology - insights.citeline.com
Merck & Co., Inc. (MRK): Jim Cramer Agrees – “Merck’s A Good Company” - Insider Monkey
Merck & Co. Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Jim Cramer Says He Likes Bristol-Myers Squibb (BMY) More Than Merck Due to Schizophrenia Drug - Yahoo Finance
Arvinas, Entrada cut staff; Merck builds US hub for Keytruda - BioPharma Dive
June 13th Options Now Available For Merck (MRK) - Nasdaq
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know - Yahoo Finance
AmacaThera and Merck Animal Health Announce Collaboration in Animal Health - Newswire.ca
Pharmaceutical company Merck to invest $1 billion in Delaware plant - The American Bazaar
Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months? - Yahoo Finance
In Brief: Merck To Invest $1bn In New US Biologics Production - insights.citeline.com
Merck & Co courts Washington with Delaware build statement - The Pharma Letter
Merck Shareholder Drops Suit Against Execs Over Gardasil Demand - Bloomberg Law News
Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential - Insider Monkey
Guggenheim Adjusts Merck & Co.'s Price Target to $108 From $115 - marketscreener.com
Guggenheim cuts Merck stock target to $108, keeps Buy rating By Investing.com - Investing.com India
Merck (MRK) Price Target Reduced by Guggenheim Analyst | MRK Sto - GuruFocus
Merck & Co. (MRK) Looks to New Cholesterol Drug as Keytruda Expiration Looms - TipRanks
Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - GlobeNewswire Inc.
Press Release Distribution & PR Platform - ACCESS Newswire
Merck plans to move manufacturing of its biggest drug, Keytruda, to a new US factory and lab in Delaware - The Daily Gazette
Merck breaks ground at Chestnut Run - WDEL.com
How To Put $100 In Your Retirement Fund Each Month With Merck Stock - Benzinga
Merck to invest $1 billion in new Delaware plant to boost US manufacturing - Reuters
Merck plans to bring Keytruda production to the US with $1B biologics factory - Endpoints News
Is Merck & Co., Inc. (MRK) the Worst-Performing Blue Chip Stock So Far in 2025? - Insider Monkey
Merck to build $1B biologics center in Wilmington - The Business Journals
Merck Begins Construction of $1 Billion Biologics Facility in Delaware - marketscreener.com
1.41%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):